Sophoricoside ameliorates cardiac hypertrophy by activating AMPK/mTORC1-mediated autophagy

Aim: The study aims to evaluate protective effects of sophoricoside (Sop) on cardiac hypertrophy. Meanwhile, the potential and significance of Sop should be broadened and it should be considered as an attractive drug for the treatment of pathological cardiac hypertrophy and heart failure. Methods: U...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Biosci Rep
Hlavní autoři: Gao, Maomao, Hu, Fengjiao, Hu, Manli, Hu, Yufeng, Shi, Hongjie, Zhao, Guo-Jun, Jian, Chongshu, Ji, Yan-Xiao, Zhang, Xiao-Jing, She, Zhi-Gang, Li, Hongliang, Zhu, Lihua
Médium: Artigo
Jazyk:Inglês
Vydáno: Portland Press Ltd. 2020
Témata:
Cardiovascular System & Vascular Biology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7677750/
https://ncbi.nlm.nih.gov/pubmed/32964914
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1042/BSR20200661
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky